ES520820A0 - Un procedimiento para la preparacion de derivados de pirrolidina. - Google Patents
Un procedimiento para la preparacion de derivados de pirrolidina.Info
- Publication number
- ES520820A0 ES520820A0 ES520820A ES520820A ES520820A0 ES 520820 A0 ES520820 A0 ES 520820A0 ES 520820 A ES520820 A ES 520820A ES 520820 A ES520820 A ES 520820A ES 520820 A0 ES520820 A0 ES 520820A0
- Authority
- ES
- Spain
- Prior art keywords
- procedure
- preparation
- pirrolidine
- derivatives
- pirrolidine derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical class C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH4849/81A CH647234A5 (en) | 1981-07-24 | 1981-07-24 | Pyrrolidine derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8404678A1 ES8404678A1 (es) | 1984-05-16 |
ES520820A0 true ES520820A0 (es) | 1984-05-16 |
Family
ID=4283624
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES520820A Granted ES520820A0 (es) | 1981-07-24 | 1983-03-22 | Un procedimiento para la preparacion de derivados de pirrolidina. |
Country Status (10)
Country | Link |
---|---|
JP (1) | JPS5824558A (es) |
KR (1) | KR890000768B1 (es) |
BR (1) | BR8204328A (es) |
CH (1) | CH647234A5 (es) |
ES (1) | ES520820A0 (es) |
GR (1) | GR76177B (es) |
IS (1) | IS2742A7 (es) |
MW (1) | MW2682A1 (es) |
PL (1) | PL138918B1 (es) |
ZA (1) | ZA825104B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH666891A5 (de) * | 1985-11-26 | 1988-08-31 | Lonza Ag | 4-alkoxy-2-oxo-pyrrolidin-1-yl-essigsaeure-c(1)-c(4)-alkylester, deren herstellung und verwendung. |
KR100498268B1 (ko) * | 1997-12-09 | 2005-11-01 | 주식회사 엘지생활건강 | 피롤리돈계 양쪽성 계면활성제 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2923975A1 (de) * | 1979-06-13 | 1980-12-18 | Nattermann A & Cie | Pyrrolidinone, verfahren zu deren herstellung und diese enthaltende arzneimittel |
-
1981
- 1981-07-24 CH CH4849/81A patent/CH647234A5/de not_active IP Right Cessation
-
1982
- 1982-06-22 IS IS2742A patent/IS2742A7/is unknown
- 1982-07-12 MW MW26/82A patent/MW2682A1/xx unknown
- 1982-07-16 ZA ZA825104A patent/ZA825104B/xx unknown
- 1982-07-22 GR GR68825A patent/GR76177B/el unknown
- 1982-07-23 PL PL1982237634A patent/PL138918B1/pl unknown
- 1982-07-23 JP JP57127795A patent/JPS5824558A/ja active Granted
- 1982-07-23 KR KR8203307A patent/KR890000768B1/ko not_active IP Right Cessation
- 1982-07-23 BR BR8204328A patent/BR8204328A/pt unknown
-
1983
- 1983-03-22 ES ES520820A patent/ES520820A0/es active Granted
Also Published As
Publication number | Publication date |
---|---|
PL138918B1 (en) | 1986-11-29 |
JPH0345064B2 (es) | 1991-07-09 |
ZA825104B (en) | 1983-04-27 |
IS2742A7 (is) | 1983-01-25 |
ES8404678A1 (es) | 1984-05-16 |
MW2682A1 (en) | 1984-03-14 |
PL237634A1 (en) | 1984-01-30 |
KR840000489A (ko) | 1984-02-22 |
BR8204328A (pt) | 1983-07-19 |
KR890000768B1 (ko) | 1989-04-05 |
JPS5824558A (ja) | 1983-02-14 |
CH647234A5 (en) | 1985-01-15 |
GR76177B (es) | 1984-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES517542A0 (es) | Un procedimiento para la preparacion de derivados de 3-hidroxi-ml-236-b. | |
ES518225A0 (es) | Un procedimiento para la preparacion de nuevos derivados de oxabicicloalcano. | |
ES517222A0 (es) | Un procedimiento para la preparacion de derivados de acilmorrfinano. | |
ES514264A0 (es) | Un procedimiento para la preparacion de derivados de tiazolidi-nilalquilen-piperazinas. | |
ES512880A0 (es) | Un procedimiento para la preparacion de derivados de 4-anilino-pirimidina. | |
ES509437A0 (es) | Un procedimiento para la preparacion de derivados carbapenen-2-tio-sustituidos. | |
ES516825A0 (es) | Un procedimiento para la preparacion de nuevos derivados de 3-amino-pregn-5-eno. | |
ES513880A0 (es) | Un procedimiento para la preparacion de derivados de triazolurea. | |
ES510067A0 (es) | Un procedimiento para la preparacion de nuevos derivados de benzoilurea. | |
ES521471A0 (es) | Un procedimiento para la preparacion de un derivado de carbostirilo. | |
ES522386A0 (es) | Un procedimiento para la preparacion de derivados de benzotiazolina. | |
ES511224A0 (es) | Un procedimiento para la preparacion de nuevos derivados de 2-piperazino pirimioina. | |
ES510611A0 (es) | Un procedimiento para la preparacion de derivados de desoxiuridina. | |
ES513967A0 (es) | Un procedimiento para la preparacion de derivados de etanola-mina. | |
ES518291A0 (es) | Un procedimiento para la preparacion de un derivado de piridoindol. | |
ES514263A0 (es) | Un procedimiento para la preparacion de derivados de espiroti-azolidinil-piperazina. | |
ES514213A0 (es) | Un procedimiento para la preparacion de nuevos derivados poliprenilicos. | |
ES508775A0 (es) | Un procedimiento para la preparacion de derivados de ciclo- hepteno. | |
ES517852A0 (es) | Un procedimiento para la preparacion de derivados de bencenosulfonamidas. | |
ES521021A0 (es) | Un procedimiento para la preparacion de nuevos derivados de fosfolipidos. | |
ES514864A0 (es) | Un procedimiento para la preparacion de derivados de trifluormetanosulfonanilida. | |
ES514486A0 (es) | Un procedimiento para la preparacion de derivados de aminonaftaceno. | |
ES520078A0 (es) | Un procedimiento para la preparacion de un derivado de b -lactama. | |
ES515365A0 (es) | Un procedimiento para la preparacion de un derivado de furanocremona. | |
ES520820A0 (es) | Un procedimiento para la preparacion de derivados de pirrolidina. |